NEW YORK, March 7 (GenomeWeb News) - Toni Schuh will serve as the new CEO of Arcturus, the company said today, almost exactly a month after Schuh stepped down as CEO of Sequenom.
Arcturus Bioscience, a privately held firm based in
Schuh succeeds former CEO and founder Thomas Baer, who resigned in late 2004 to serve as a consulting professor in the Applied Physics department at
Baer continues to serve as a director of Arcturus. Richard Kniss, who has served as a member of the Arcturus Board since January 2002, will be appointed non-executive chairman, the company said.
Arcturus sells laser capture microdissection systems for the isolation of single cells, as well as reagents for genomic analysis of microscopic tissue samples.